DIFFERENTIAL EFFECT ON TCR-CD3 STIMULATION OF A 90-KD GLYCOPROTEIN (GP90 MAC-2BP), A MEMBER OF THE SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN PROTEIN FAMILY/
B. Silvestri et al., DIFFERENTIAL EFFECT ON TCR-CD3 STIMULATION OF A 90-KD GLYCOPROTEIN (GP90 MAC-2BP), A MEMBER OF THE SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN PROTEIN FAMILY/, Clinical and experimental immunology, 113(3), 1998, pp. 394-400
We studied the effects of a 90-kD glycoprotein (gp90/Mac-2BP) belongin
g to the scavenger receptor family, present in normal serum and at inc
reased levels in inflammatory disease and cancer patients, on some T c
ell function parameters. Whereas the lymphocyte proliferative response
to non-specific mitogens such as phytohaemagglutinin (PHA) and concan
avalin A (Con A), but not pokeweed mitogen (PWM), was strongly reduced
, probably due to the lectin-binding properties of gp90/Mac-2BP, the r
esponse to T cell receptor (TCR) agonists such as superantigens and al
logeneic cells was potentiated. When lymphocytes were stimulated with
different anti-TCR:CDS MoAbs, both in soluble and solid-phase form, gp
90/Mac-2BP was able to down-regulate the proliferative response to ant
i-CD3 MoAb, whereas the response to anti-TCR alpha beta MoAb was enhan
ced. A similar differential effect was observed when a MoAb against CD
5 (another member of the scavenger receptor superfamily) was added to
anti-CD3 or anti-TCR-stimulated cells; anti-CDS MoAb strongly down-mod
ulated the CD3-mediated response, whereas its presence in culture was
associated with potentiation of the response to TCR alpha beta agonist
s. gp90/Mac-2BP was able per se to up-regulate Ca2+ levels in freshly
isolated lymphocytes; moreover, its presence in culture was associated
with increased Ca2+ mobilization following stimulation with anti-TCR
alpha beta, but not anti-CD3 MoAb. These data indicate that gp90/Mac-2
BP could be able to influence some immune responses, possibly through
multiple homologous interactions with other members of the scavenger r
eceptor family; moreover, our findings suggest that signalling through
the different components of the TCR:CD3 complex may follow distinct a
ctivation pathways into the cells.